Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC
Clinical trial NCT03792269 · UNKNOWN
Trial details
- NCT number
- NCT03792269
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2019-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.